220 related articles for article (PubMed ID: 2411245)
1. Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?
Yoden S; Kida H; Yanagawa R
Arch Virol; 1985; 85(3-4):209-16. PubMed ID: 2411245
[TBL] [Abstract][Full Text] [Related]
2. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
Williams JA; Gui L; Hom N; Mileant A; Lee KK
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus.
Kida H; Webster RG; Yanagawa R
Arch Virol; 1983; 76(2):91-9. PubMed ID: 6191738
[TBL] [Abstract][Full Text] [Related]
4. Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments.
Schofield DJ; Stephenson JR; Dimmock NJ
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2431-9. PubMed ID: 9349461
[TBL] [Abstract][Full Text] [Related]
5. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin.
Brown LE; Murray JM; White DO; Jackson DC
Arch Virol; 1990; 114(1-2):1-26. PubMed ID: 1699509
[TBL] [Abstract][Full Text] [Related]
6. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
Edwards MJ; Dimmock NJ
J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
[TBL] [Abstract][Full Text] [Related]
7. A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity.
Edwards MJ; Dimmock NJ
J Gen Virol; 2001 Jun; 82(Pt 6):1387-1395. PubMed ID: 11369883
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of neutralization of influenza virus infectivity by antibodies.
Knossow M; Gaudier M; Douglas A; Barrère B; Bizebard T; Barbey C; Gigant B; Skehel JJ
Virology; 2002 Oct; 302(2):294-8. PubMed ID: 12441073
[TBL] [Abstract][Full Text] [Related]
9. Interference with a conformational change in the haemagglutinin molecule of influenza virus by antibodies as a possible neutralization mechanism.
Kida H; Yoden S; Kuwabara M; Yanagawa R
Vaccine; 1985 Sep; 3(3 Suppl):219-22. PubMed ID: 4060852
[TBL] [Abstract][Full Text] [Related]
10. Quantitative relationships between an influenza virus and neutralizing antibody.
Taylor HP; Armstrong SJ; Dimmock NJ
Virology; 1987 Aug; 159(2):288-98. PubMed ID: 3617501
[TBL] [Abstract][Full Text] [Related]
11. Antigenic analysis of recent H1N1 influenza viruses with monoclonal antibodies.
Yamada A; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S
Acta Virol; 1991 Aug; 35(4):343-9. PubMed ID: 1724874
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus.
Tozawa H; Komatsu H; Ohkata K; Nakajima T; Watanabe M; Tanaka Y; Arifuku M
Arch Virol; 1986; 91(1-2):145-61. PubMed ID: 2428330
[TBL] [Abstract][Full Text] [Related]
13. Comparative investigation of monoclonal and polyclonal antibodies directed against strain-specific and common antigenic sites on influenza H1N1 virus hemagglutinin.
Drescher J; Verhagen W; Flik J; Stachan R
Intervirology; 1987; 27(4):205-17. PubMed ID: 2447032
[TBL] [Abstract][Full Text] [Related]
14. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.
Nelson CD; Palermo LM; Hafenstein SL; Parrish CR
Virology; 2007 May; 361(2):283-93. PubMed ID: 17217977
[TBL] [Abstract][Full Text] [Related]
15. Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody.
Yoden S; Kida H; Kuwabara M; Yanagawa R; Webster RG
Virus Res; 1986 May; 4(3):251-61. PubMed ID: 3017016
[TBL] [Abstract][Full Text] [Related]
16. The stoichiometry of binding between monoclonal antibody molecules and the hemagglutinin of influenza virus.
Poumbourios P; Brown LE; White DO; Jackson DC
Virology; 1990 Dec; 179(2):768-76. PubMed ID: 1700542
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies.
Gitelman AK; Kaverin NV; Kharitonenkov IG; Rudneva IA; Sklyanskaya EL; Zhdanov VM
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2247-51. PubMed ID: 3760825
[TBL] [Abstract][Full Text] [Related]
18. Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: influence of receptor specificity.
Yamada A; Brown LE; Webster RG
Virology; 1984 Oct; 138(2):276-86. PubMed ID: 6208682
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus.
Kida H; Brown LE; Webster RG
Virology; 1982 Oct; 122(1):38-47. PubMed ID: 6182687
[No Abstract] [Full Text] [Related]
20. Antigenic determinants of influenza virus hemagglutinin. VIII. Topography of the antigenic regions of influenza virus hemagglutinin determined by competitive radioimmunoassay with monoclonal antibodies.
Breschkin AM; Ahern J; White DO
Virology; 1981 Aug; 113(1):130-40. PubMed ID: 6168097
[No Abstract] [Full Text] [Related]
[Next] [New Search]
